Zobrazeno 1 - 10
of 283
pro vyhledávání: '"A. G Avtandilov"'
Publikováno v:
КардиоСоматика, Vol 9, Iss 4, Pp 32-37 (2018)
Heart failure with preserved fraction (HFpEF) amount for a half of the general heart failure and increasing progressively. In this review we discuss the issues of pathogenesis of HFpEF, illuminated in the recent literature in the last years. Consider
Externí odkaz:
https://doaj.org/article/d1dc10d5ecb34c2795a17f69b62c8796
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 16, Iss 3, Pp 377-382 (2020)
Aim. To assess the effect of combination therapy (perindopril, indapamide, amlodipine) on vascular stiffness and endothelial function in patients with heart failure with preserved ejection fraction (HFpEF).Material and methods. Patients with HFpEF (n
Externí odkaz:
https://doaj.org/article/c0895eadb7dc451eae53f87a6af21c6f
Autor:
Z. M. Akhilgova, A. P. Roitman, N. G. Rakova, A. V. Bugrov, E. A. Pavlovskaya, M. S. Zastrozhin, A. G. Avtandilov
Publikováno v:
Российский кардиологический журнал, Vol 26, Iss 5 (2021)
Aim. To study the effect of triple combination therapy on oxidative stress and arterial remodeling in hypertensive patients with heart failure with preserved ejection fraction (HFpEF).Material and methods. The study involved 76 people with diagnosed
Externí odkaz:
https://doaj.org/article/16c7908c87254ac49424253d9beada83
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 8, Pp 36-43 (2019)
Aim. To determine the dynamics of endothelial function and intracardiac hemodynamics during implantation of different types of pacemakers.Material and methods. The study involved 61 patients, 29 of them were implanted with single-chamber pacemaker (t
Externí odkaz:
https://doaj.org/article/7f0e24f5162b460cb47c756462219108
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 13, Iss 5, Pp 615-621 (2017)
Aim. To study the combination and contribution of risk factors (age, hypertension (HT), obesity, diabetes mellitus, chronic kidney disease (CKD), length of illness) leading to the formation of chronic heart failure (CHF) with preserved ejection fract
Externí odkaz:
https://doaj.org/article/790cf25aad5a41628f6f5d5782570a62
Autor:
L. V. Didenko, E. A. Ulubieva, T. G. Borovaya, A. G. Avtandilov, N. V. Shevlyagina, V. G. Zhukhovitsky, O. M. Grinkevich, M. V. Mezentseva
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 13, Iss 1, Pp 88-94 (2017)
Aim. To study changes in the glycoproteins content in the glycocalyx of endothelial cells under the influence of magnesium orotate.Material and methods. Endotheliocytes of cell culture EA.hy 926 were examined before and after addition of the magnesiu
Externí odkaz:
https://doaj.org/article/f19a957f226f4d18af26ef873f886e15
Autor:
R. R. Kushkhova, A. G. Avtandilov
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 12, Iss 4, Pp 396-402 (2016)
Aim. To study morphometric changes of the left ventricle (LV) and characteristics of peripheral hemodynamics in patients with drug resistant hypertension (HT).Material and methods. In total, 120 patients with unmanageable HT of 2-3 degrees, that cons
Externí odkaz:
https://doaj.org/article/e37dcd5aa4f240d7828b2d6beadc7d0b
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 12, Iss 2, Pp 176-179 (2016)
Aim. To study the doctor awareness of the criteria of resistant hypertension (RHT) and to evaluate the features of the combination therapy of RTH patients in outpatient clinics. Material and methods. An analysis of medical records of patients with hy
Externí odkaz:
https://doaj.org/article/d7cab43b01a6470fa706b815d7e44792
Autor:
E. A. Ulubieva, A. G. Avtandilov
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 12, Iss 1, Pp 87-93 (2016)
Recent scientific data on the influence of magnesium on the cardiovascular and reproductive system in women is summarized. Evidence-based medicine data has shown a link between magnesium blood (plasma, red blood cells) levels and increased risk of so
Externí odkaz:
https://doaj.org/article/db948bf5a54e47ae8da804e494a6e4b9
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 6, Iss 5, Pp 677-684 (2016)
Mitral valve prolapse (MVP) is a manifestation of the hereditary syndrome of differentiated or undifferentiated connective tissue dysplasia (CTD). Genetic defect of synthesis and/or degradation of extracellular matrix is the basis of the CTD. MVP is
Externí odkaz:
https://doaj.org/article/cf406dd2efbb4902a9470504f58527fc